Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients

By Birjmohun R. S.   Kastelein J. J. P.   Poldermans D.   Stroes E. S. G   Hostalek U.   Assmann G.  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1707-1713

Informa Healthcare

Access to resources Recommend Favorite

Lipoprotein lipase Hin dIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease

By Javorský Martin   Gašperíková Daniela   Ukropec Jozef   Sedláková Barbora   Riečanský Igor   Križanová Ol'ga   Šeböková Elena   Dobríková Martina   Klimeš Iwar   Tkáč Ivan  

Wiener klinische Wochenschrift, Vol. 119, Iss. 15-16, 2007-08 ,pp. : 476-482

Springer Publishing Company

Access to resources Recommend Favorite

Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care

By Bestehorn Kurt   Smolka Wenefrieda   Pittrow David   Schulte Helmut   Assmann Gerd  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2833-2839

Informa Healthcare

Access to resources Recommend Favorite

ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients

By Liem A. H.   van de Woestijne A. P.   Roeters van Lennep H. W. O.   Zwinderman A. H.   van der Steeg W. A.   Jukema J. W.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 359-364

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of dyslipidaemia in statin-treated patients in Ireland: Irish results of the DYSlipidaemia International Study (DYSIS)

By Horgan S.  

Irish Journal of Medical Science, Vol. 180, Iss. 2, 2011-06 ,pp. : 343-349

Springer Publishing Company

Access to resources Recommend Favorite